MannKind Corporation

391 articles about MannKind Corporation

• MannKind Corporation Wins Two Facility of the Year 2010 Category Awards

  1/11/2010

• MannKind Corporation Updates Status of New Drug Application; FDA to Delay Review of Insulin Device

  1/11/2010

• MannKind Corporation Faces Crucial Test on Insulin Device; Many Bet it Will Fail

  1/6/2010

• MannKind Corporation to Present at the 28th Annual J.P. Morgan Healthcare Conference

  1/5/2010

• MannKind Corporation to Present at Upcoming Conferences

  11/3/2009

• Studies Show Early Promise of MannKind Corporation's Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid Malignancies

  10/29/2009

• MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 2, 2009

  10/27/2009

• MannKind Corporation Says No Afresa Partnership In 2009

  10/7/2009

• MannKind Corporation: AFRESA(R) Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment

  10/2/2009

• MannKind Corporation to Present at Upcoming Conferences

  9/4/2009

• MannKind Corporation to Present at the 29th Annual Canaccord Adams Global Growth Conference

  8/6/2009

• MannKind Corporation 2Q Loss Narrows on Lower Expenses

  8/4/2009

• MannKind Corporation Announces Positive New Market Survey Information Regarding AFRESA(R)

  7/15/2009

• MannKind Corporation Unveils Next-Generation Inhalation System

  6/8/2009

• MannKind Corporation to Present at the Needham Life Sciences Conference

  6/3/2009

• Emisphere Technologies, Inc. Receives Milestone Payment from MannKind Corporation

  5/21/2009

• FDA Accepts MannKind Corporation's Submission and Files NDA for AFRESA

  5/18/2009

• MannKind Corporation to Present at the Canaccord Adams Diabetes and Obesity Conference

  5/5/2009

• MannKind Corporation Reports First Quarter of 2009 Financial Results

  5/4/2009

• MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 4, 2009

  4/27/2009